Heat score
1Topic analysis
Cancer jab can eradicate entire tumours in patients, trial shows
Trial results show a triple - action cancer jab (amivantamab) eradicated tumors in treatment - resistant patients across 11 countries; 15 patients saw complete tumor elimination, patient Carl Walsh recovered, median survival was 12.5 months, and the jab’s convenience and mild side effects were noted, hailed as 'unprecedented' progress.
Sources
1Platforms
1Relations
0- First seen
- May 31, 2026, 1:00 AM
- Last updated
- May 31, 2026, 4:28 AM
Why this topic matters
Cancer jab can eradicate entire tumours in patients, trial shows is currently shaped by signals from 1 source platforms. This page organizes AI analysis summaries, 1 timeline events, and 0 relationship edges so search engines and AI systems can understand the topic's factual basis and propagation arc.
News
Keywords
13 tagscancer jabamivantamabcancer trialtumour eradicationchemotherapy resistanceimmunotherapy resistanceinternational trialhead and neck cancerlung cancerCarl Walshmedian survivalside effectsHPV - negative
Source evidence
1 evidence itemsCancer jab can eradicate entire tumours in patients, trial shows
News · 1May 31, 2026, 1:00 AMOpen original source
Timeline
Cancer jab can eradicate entire tumours in patients, trial shows
May 31, 2026, 1:00 AM
Related topics
No related topics have been aggregated yet, but this page still preserves the AI summary, source links, and timeline.